Abstract:FP prostanoid receptors are G-protein-coupled receptors whose physiological activator is prostaglandin-F-2 alpha ( PGF(2 alpha)). PGF(2 alpha) has been implicated in wound healing and cardiac hypertrophy, which are both known to involve the induction of the immediate-early response gene, early growth response factor-1 (EGR-1). We hypothesized that activation of the human FP receptor by PGF(2 alpha) could induce the expression of EGR-1 and found that 1 mu M PGF(2 alpha) produced a time-dependent induction of both mRNA and protein expression for EGR-1. This FP receptor-mediated induction of EGR-1 expression involved activation of the small GTPase Ras followed by activation of C-Raf and the mitogen-activated protein (MAP) kinase kinases 1 and 2 (MEK1/2). Thus, induction of EGR-1 expression by PGF(2 alpha) was blocked using dominant-negative constructs of Ras and C-Raf and the Raf kinase inhibitor 4-(4-(3-(4-chloro-3-trifluoromethylphenyl)ureido)phenoxy)- pyridine-2-carboxyllic acid methyamide-4-methylbenzenesulfonate (BAY43-9006). Likewise, the MEK1/2 inhibitor 2'-amino-3'methoxyflavone (PD98059) blocked the induction of EGR-1 expression by PGF(2 alpha). FP receptor stimulation by PGF(2 alpha) induced the phosphorylation of C-Raf, MEK1/ 2, and extracellular signal-regulated kinases 1 and 2, consistent with the activation of a MAP kinase signaling cascade. PGF(2 alpha) was also found to induce the expression of EGR-1 in rat cardiomyocytes through the activation of endogenous FP receptors. This induction of EGR-1 expression in cardiomyocytes also involved the activation of Raf and MAP kinase signaling and was dependent on the activation of protein kinase C. This is the first report to show the regulation of EGR-1 expression after PGF(2 alpha) activation of FP receptors and suggests that this could be an early event involved in wound healing and cardiac hypertrophy.

FP receptor structures reveal the selectivity mechanism of prostaglandin

Structures of Human Prostaglandin F2α Receptor Reveal the Mechanism of Ligand and G Protein Selectivity.

Structures of human prostaglandin F 2α receptor reveal the mechanism of ligand and G protein selectivity

Structural Basis for Ligand Recognition and Activation of the Prostanoid Receptors

Ligand recognition, unconventional activation, and G protein coupling of the prostaglandin E<sub>2</sub> receptor EP2 subtype

Single Hormone or Synthetic Agonist Induces Gs/Gi Coupling Selectivity of EP Receptors Via Distinct Binding Modes and Propagating Paths.

Structural Insights into Selective and Dual Antagonism of EP2 and EP4 Prostaglandin Receptors

Universal mechanism of hormone and allosteric agonist mediated activation of glycoprotein hormone receptors as revealed by structures of follicle stimulating hormone receptor

Molecular cloning and expression of prostaglandin F2α receptor isoforms during ovulation in the ovarian follicles of Xenopus laevis.

Ligand recognition, unconventional activation, and G protein coupling of the prostaglandin E 2 receptor EP2 subtype

Structural Basis for Iloprost as a Dual Peroxisome Proliferator-activated Receptor α/δ Agonist

Molecular recognition and activation of the prostacyclin receptor by anti-pulmonary arterial hypertension drugs

Crystal Structure of Misoprostol Bound to the Labor Inducer Prostaglandin E 2 Receptor

Structure and Drug Development of the Human Formylpeptide Receptors FPR1 and FPR2.

Fp Prostanoid Receptor-Mediated Induction Of The Expression Of Early Growth Response Factor-1 By Activation Of A Ras/Raf/Mitogen-Activated Protein Kinase Signaling Cascade

Molecular recognition of formylpeptides and diverse agonists by the formylpeptide receptors FPR1 and FPR2

Characterization of a Rabbit Kidney Prostaglandin F2α Receptor Exhibiting Gi-restricted Signaling That Inhibits Water Absorption in the Collecting Duct

Expression of Relaxant EP2 and Contractile FP in Human Lower Segment Myometrium in Term Pregnancy and Labor

Discovery of 13-oxa prostaglandin analogs as antiglaucoma agents: Synthesis and biological activity

Research Progress of Prostaglandin Receptors and Related Drugs

Mechanism of hormone and allosteric agonist mediated activation of follicle stimulating hormone receptor